Status:
NOT_YET_RECRUITING
Biphasic Material With PRF in Lateral Sinus Floor Augmentation
Lead Sponsor:
Assiut University
Conditions:
Maxillary Sinus Disease
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
A lack of bone in the posterior maxilla, mainly resulting from the combination of alveolar bone resorption after tooth loss, pneumatization of the maxillary sinus, and periodontal disease, leads to in...
Detailed Description
Recently, a systematic review demonstrated the effectiveness of synthetic bone materials, including biphasic calcium phosphate (BCP), as substitutes for autogenous bone. BCP consists of hydroxyapatite...
Eligibility Criteria
Inclusion
- Residual bone crest height \< 5 mm and width≥6 mm in the planned implant site.
- Healed bone crest (at least 6 months elapsed from tooth loss/extraction);
Exclusion
- Absolute medical contraindications to implant surgery such as uncontrolled diabetes mellitus, blood platelet disorders, serious osseous disorders, and cardiac arrhythmia; history of bone grafting in the posterior maxilla, immunocompromised patients, taking corticosteroids, taking aspirin before the procedure, positive history of chemotherapy and radiotherapy, and maxillary sinus pathologies
Key Trial Info
Start Date :
February 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2024
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT06071416
Start Date
February 15 2024
End Date
April 1 2024
Last Update
January 31 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.